1. Home
  2. ITRM vs AWRE Comparison

ITRM vs AWRE Comparison

Compare ITRM & AWRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ITRM
  • AWRE
  • Stock Information
  • Founded
  • ITRM 2015
  • AWRE 1986
  • Country
  • ITRM Ireland
  • AWRE United States
  • Employees
  • ITRM N/A
  • AWRE N/A
  • Industry
  • ITRM Biotechnology: Pharmaceutical Preparations
  • AWRE Computer Software: Prepackaged Software
  • Sector
  • ITRM Health Care
  • AWRE Technology
  • Exchange
  • ITRM Nasdaq
  • AWRE Nasdaq
  • Market Cap
  • ITRM 36.3M
  • AWRE 34.6M
  • IPO Year
  • ITRM 2018
  • AWRE 1996
  • Fundamental
  • Price
  • ITRM $0.97
  • AWRE $1.67
  • Analyst Decision
  • ITRM Strong Buy
  • AWRE
  • Analyst Count
  • ITRM 2
  • AWRE 0
  • Target Price
  • ITRM $7.00
  • AWRE N/A
  • AVG Volume (30 Days)
  • ITRM 515.1K
  • AWRE 25.5K
  • Earning Date
  • ITRM 05-13-2025
  • AWRE 04-30-2025
  • Dividend Yield
  • ITRM N/A
  • AWRE N/A
  • EPS Growth
  • ITRM N/A
  • AWRE N/A
  • EPS
  • ITRM N/A
  • AWRE N/A
  • Revenue
  • ITRM N/A
  • AWRE $16,576,000.00
  • Revenue This Year
  • ITRM N/A
  • AWRE N/A
  • Revenue Next Year
  • ITRM $108.39
  • AWRE N/A
  • P/E Ratio
  • ITRM N/A
  • AWRE N/A
  • Revenue Growth
  • ITRM N/A
  • AWRE N/A
  • 52 Week Low
  • ITRM $0.81
  • AWRE $1.35
  • 52 Week High
  • ITRM $3.02
  • AWRE $2.97
  • Technical
  • Relative Strength Index (RSI)
  • ITRM 45.57
  • AWRE 53.50
  • Support Level
  • ITRM $0.93
  • AWRE $1.60
  • Resistance Level
  • ITRM $1.05
  • AWRE $1.73
  • Average True Range (ATR)
  • ITRM 0.05
  • AWRE 0.08
  • MACD
  • ITRM 0.01
  • AWRE 0.00
  • Stochastic Oscillator
  • ITRM 50.00
  • AWRE 55.16

About ITRM Iterum Therapeutics plc

Iterum Therapeutics PLC is a pharmaceutical company dedicated to maximizing the commercial potential of Orlynvah, an oral-branded penem available in the United States and potentially the first and only oral and intravenous (IV) branded penem available globally. Its product Orlynvah has the potential to be a treatment for complicated urinary tract infections caused by the designated microorganisms, without the presence of known toxicities of some other antibiotics. The company operates in a single business segment, which is the development and commercialization of treatments for drug-resistant bacterial infections.

About AWRE Aware Inc.

Aware Inc is a provider of software and services to the biometrics industry. The company's software products are used in government and commercial biometrics systems to identify or authenticate people. The government applications of biometrics systems include border control, visa applicant screening, law enforcement, national defense, intelligence, secure credentialing, access control, and background checks. Its commercial applications include user authentication for login to mobile devices, computers, networks, and software programs, user authentication for financial transactions and purchases. Its geographical segments include the United States, the United Kingdom, and the Rest of the world, out of which it derives maximum revenue from United States.

Share on Social Networks: